Alsip, Illinois Clinical Trials

A listing of Alsip, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 182 clinical trials
The ARIES HeartMate 3 Pump IDE Study

Prospective, randomized, double-blinded, placebo-controlled clinical investigation of advanced heart failure patients treated with the HM3 with two different antithrombotic regimens: vitamin K antagonist with aspirin versus vitamin K antagonist with placebo

heart failure
aspirin
Advocate Christ Medical Center
 (3.5 away) Contact site
  • 5 views
  • 07 Aug, 2021
  • +33 other locations
Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer

Primary Objective: To determine whether Amcenestrant (SAR439859) in combination with palbociclib improvesprogression free survival (PFS) when compared with letrozole in combination with palbociclib in participants with ER+, HER2- advanced breast cancer who have not received any prior systemic anticancer therapies for advanced disease. Secondary Objective: To compare the overall survival …

measurable disease
HER2
erbb2
palbociclib
advanced breast cancer
Investigational Site Number 8400079
 (3.1 away) Contact site
  • 0 views
  • 08 Jul, 2021
  • +196 other locations
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone

The main objective of this study is to evaluate the efficacy of SZC as compared with placebo in keeping potassium levels within the normal range (3.5-5.0 mEq/L) while on spironolactone 25 mg daily without assistance of rescue therapy for hyperkalaemia (HK).

Research Site
 (7.1 away) Contact site
  • 0 views
  • 29 Aug, 2021
  • +52 other locations
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure Obesity and Type 2 Diabetes

This study will look at how participants' daily life is affected by their heart failure. The study will also look at the change in participants' body weight. This study will compare the effect of semaglutide (a new medicine) compared to "dummy" medicine on body weight and heart failure symptoms. Participants …

Novo Nordisk Investigational Site
 (7.1 away) Contact site
  • 7 views
  • 26 Sep, 2021
  • +59 other locations
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

This randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men with prostate cancer that has spread to other places in the body (metastatic) and has become resistant to testosterone-deprivation therapy (castration-resistant). Enzalutamide helps fight prostate cancer …

Ingalls Memorial Hospital
 (6.2 away) Contact site
  • 0 views
  • 22 Aug, 2021
  • +259 other locations
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD)

fluvoxamine
clomipramine
serotonin reuptake inhibitors
Healthcare Research Network II, LLC
 (9.3 away) Contact site
  • 19 views
  • 02 Sep, 2021
  • +89 other locations
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cervical cancer that has spread to other parts of the body (metastatic) or has come back after being treated (recurrent). Participants in this trial will be …

measurable disease
chemotherapy drugs
treatment regimen
immunomodulator
paclitaxel
Gynecological Cancer Institute of Chicago, LLC
 (3.5 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +39 other locations
CHAMPION-AF Clinical Trial

The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

left atrial appendage closure
vascular disease
anticoagulants
fibrillation
noac
Advocate Christ Medical Center
 (3.5 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +92 other locations
Global Prevalence of ATTR-CM in Participants With HFpEF

This study is a global, multi-center study designed to estimate the global prevalence of transthyretin amyloid cardiomyopathy (ATTR-CM) within a clinically at risk population [participants with heart failure with preserved ejection fraction (HFpEF)].

Chicago Medical Research, LLC
 (7.1 away) Contact site
  • 0 views
  • 20 Sep, 2021
  • +23 other locations
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical …

Ingalls Memorial Hospital
 (6.2 away) Contact site
  • 6 views
  • 12 Sep, 2021
  • +368 other locations